In Brief

In Brief

Guideline on HER2 Testing for Patients with Gastric Cancer

THE COLLEGE OF AMERICAN PATHOLOGISTS, the American Society for Clinical Pathology, and the American Society of Clinical Oncology released an evidence-based clinical practice guideline on human epidermal growth factor receptor 2 (HER2) testing for patients with gastroesophageal cancers. The guideline provides recommendations about appropriate HER2 testing for patients at key decision points throughout their cancer... […]
In Brief

Cedars-Sinai adds radiation oncology with treatment center

CEDARS-SINAI added a treatment center offering radiation oncology therapies less than a mile from the hospital campus. The center will be a collaboration with Integrated Oncology Network, LLC. The 8,500-square-foot facility, at 8929 Wilshire Blvd. in Beverly Hills, will be fully integrated into the Cedars-Sinai medical record system making available lab tests, X-rays and reports.... […]
In Brief

Feinstein Institute researcher introduces app to help patients with treatment options

MICHAEL DIEFENBACH, the Feinstein Institute for Medical Research scientist and Northwell Health director of Behavioral Research in the Department of Medicine and Urology, demonstrated an app to help with decision-making for prostate cancer treatment. Prostate cancer patients face a variety of treatment options ranging from immediate surgery and/or radiation to health care professionals observing the... […]
In Brief

Elisabeth Heath, of Karmanos, receives the Michigan Cancer Consortium’s inaugural Champion Award

ELISABETH HEATH, of Karmanos Cancer Institute, was presented with the Michigan Cancer Consortium’s inaugural Champion Award for 2016 for her efforts in curbing cancer. Heath has been with Karmanos Cancer Institute since 2003, appointed director of Prostate Cancer Research in 2010, and became a full professor at Wayne State University School of Medicine in 2013.... […]
In Brief

Charles Drake joins NY-Presbyterian/Columbia as director of genitourinary oncology. associate director at the Columbia Cancer Center, co-director immunotherapy program.

CHARLES DRAKE joined New York-Presbyterian/Columbia University Medical Center as director of genitourinary oncology and associate director for clinical research at the Herbert Irving Comprehensive Cancer Center and co-director of Columbia’s Cancer Immunotherapy Program. Drake is a physician-scientist with a Ph.D. in immunology, whose work focuses on understanding and fighting advanced-stage cancers with the immune system.... […]